On December 3, 2012, in a widely anticipated ruling, the US Court of Appeals for the Second Circuit reversed the conviction of pharmaceutical sales representative Alfred Caronia for misbranding under the Federal Food, Drug and Cosmetic Act, based on alleged off-label promotion.
This Sidley Update was republished by ILO in its Healthcare & Life Sciences Newsletter.